Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial

TRIAL DESIGN: HIV-1 vaccine development has advanced slowly due to viral antigenic diversity, poor immunogenicity and recently, safety concerns associated with human adenovirus serotype-5 vectors. To tackle HIV-1 variation, we designed a unique T-cell immunogen HIVconsv from functionally conserved r...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Hayton, E, Rose, A, Ibrahimsa, U, Del Sorbo, M, Capone, S, Crook, A, Black, A, Dorrell, L, Hanke, T
פורמט: Journal article
שפה:English
יצא לאור: Public Library of Science 2014